Review achieving effective control in cancer pain: A review of current guidelines

International Journal of Palliative Nursing

Volumn 19, Issue 12, 2013, Pages 584-591

  Fielding, Flannery ^a   Sanford, Tanya M ^a   Davis, Mellar P ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Adjuvants; Cancer; Guidelines; Pain management; Titration

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; ANALGESIA; CHILD; COMPLICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; NURSING; PAIN; PATIENT CARE; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; VERY ELDERLY; WORLD HEALTH ORGANIZATION; YOUNG ADULT; METHODOLOGY; REVIEW; STANDARD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHILD; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MANAGEMENT; PATIENT-CENTERED CARE; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84891384363     PISSN: 13576321     EISSN: None     Source Type: Journal    
DOI: 10.12968/ijpn.2013.19.12.584     Document Type: Review

References (35)

1. Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R (2009) The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med 10(1):35-42
2. Candrilli SD, Davis KL, Iyer S (2009) Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy. J Pain Palliat Care Pharmacother 23(3):231-41
3. Caraceni A, Weinstein SM (2001) Classification of cancer pain syndromes. Oncology (Williston Park) 15(12):1627-42
4. Caraceni A, Hanks G, Kaasa S et al (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13(2):e58-68
5. Crews KR, Gaedigk A, Dunnenberger HM et al (2012) Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6(CYP2D6) genotype. Clin Pharmacol Ther 91 (2):321-6
6. Davis M, Goforth HW, Gamier P (2013) Oxycodone combined with opioid receptor antagonists: efficacy and safety. Expert Opin Drug Saf 12(3):389-402
7. Davis MP (2010) Recent development in therapeutics for breakthrough pain. Expert Rev Neurother 10(5):757-73
8. Davis MP (2012a) Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol 10(6):209-19
9. Davis MP (2012b) Are there cost benefits to fentanyl for breakthrough pain? J Pain Symptom Manage 44(3):e1-2
10. Dev R, Del Fabbro E, Bruera E (2011) Patient-controlled analgesia in patients with advanced cancer. Should patients be in control? J Pain Symptom Manage 42(2):296-300
11. Dulko D, Hertz E, Julien J, Beck S, Mooney K (2010) Implementation of cancer pain guidelines by acute care nurse practitioners using an audit and feedback strategy. J Am Acad Nurse Pract 22(1):45-55
12. Gaertner J, Schiessl C (2013) Cancer pain management: what's new? Curr Pain Headache Rep 17(4):328
13. Green E, Zwaal C, Beals C et al (2010) Cancer-related pain management: a report of evidence-based recommendations to guide practice. Clin J Pain 26(6):449-62
14. Hardy J, Quinn S, Fazekas B et al (2012) Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol 30(29):3611-7
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. Ca Cancer J Clin 61(2):69-90
16. Katz N, Mazer NA (2009) The impact of opioids on the endocrine system. Clin J Pain 25(2):170-5
17. Lennon FE, Moss J, Singleton PA (2012) The μ-opioid receptor in cancer progression: is there a direct effect ? Anesthesiology 116(4):940-5
18. Loeser JD (2000) Pain and suffering. Clin J Pain 16(2 Suppl):S2-6
19. McHugh ME, Miller-Saultz D, Wuhrman E, Kosharskyy B (2012) Interventional pain management in the palliative care patient. Int J Palliat Nurs 18(9):426-33
20. Mercadante S (2010) Management of cancer pain. Intern Emerg Med 5(Suppl 1):S31-5
21. Miguel R (2000) Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? Cancer Control 7(2):149-56
22. Nikles J, Mitchell GK, Schluter P et al (2011) Aggregating single patient (n-of-1) trials in populations where recruitment and retention was diffciult: the case of palliative care. J Clin Epidemiol 64(5):471-80
23. Raphael J, Ahmedzai S, Hester J et al (2010a) Cancer pain: part 1: Pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 11(5):742-64
24. Raphael J, Hester J, Ahmedzai S et al (2010b) Cancer pain: part 2: physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 11(6):872-96
25. Ripamonti CI (2012) Pain management. Ann Oncol 23(Suppl 10):x294-301
26. Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F (2012) Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 23(Suppl 7):vii139-54
27. Swarm R, Abernethy AP, Anghelescu DL et al (2010) Adult cancer pain. J Natl Compr Canc Netw 8(9):1046-86
28. Thomas JR, Cooney GA, Slatkin NE (2008) Palliative care and pain: new strategies for managing opioid bowel dysfunction. J Palliat Med 11(Suppl 1):S1-19
29. Vargas-Schaffer G (2010) Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 56(6):514-7
30. Virizuela JA, Escobar Y, Cassinello J, Borrega P (2012) Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice. Clin Transl Oncol 14(7):499-504
31. Walsh D, Rivera NI, Davis MP, Lagman R, Legrand SB (2004) Strategies for pain management: cleveland clinic foundation guidelines for opioid dosing for cancer pain. Support Cancer Ther 1(3):157-64
32. World Health Organization (1996) Cancer Pain Relief: With a Guide to Opioid Availability. 2nd edn. WHO, Geneva
33. World Health Organization (2013) Cancer. Fact sheet 297. www. Who. Int/mediacentre/factsheets/fs297/en/ (accessed 20 November 2013)
34. Wong BS, Camilleri M (2011) Lubiprostone for the treatment of opioid-induced bowel dysfunction. Expert Opin Pharmacother 12(6):983-90
35. Yamaguchi T, Shima Y, Morita T, Hosoya M, Matoba M (2013) Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations. Jpn J Clin Oncol 43(9):896-909